Press Releases  |
EMD Biosciences announces the launch of the ProteoPlex™ 16-Well Human Cytokine Array Kit
EMD Biosciences, Inc., a manufacturer of products for proteomics and disease pathway analysis, announces the launch of the ProteoPlex™16-Well Human Cytokine Array Kit. The kit provides a complete solution for determining the levels of 12 cytokines from 10 sera or tissue culture supernatants simultaneously.
Conventional cytokine measurements are based on single analyte detection requiring multiple kits and large sample volumes to test for multiple cytokines. In contrast, the ProteoPlex arrays require only 50 microliters of the sample material to determine concentrations of 12 different cytokines.
Cytokines are chemical messengers that circulate in the body. A part of the immune system, cytokines affect cell to cell communications and interactions. Certain conditions or diseases are associated with changes in the amount of more than one cytokine in the body. Thus the simultaneous quantitation of a variety of cytokines, is important to gauge the status of a cell system or organism. "For instance, if you knew only that TNFalpha was high you would know that the system was going to an inflammatory state, but you wouldn't know if the T-cells were transitioning to a Th1 or Th2 state, for that you'd need to know a few other analytes (IL1alpha, IL-4, etc.)." said Dr. Samuel LaBrie, R&D group leader for EMD Biosceinces’ Array group.
About EMD Biosciences
EMD Biosciences, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, provides innovative tools for proteomics and pathway analysis to the worldwide scientific research community through its brands Calbiochem, Novabiochem, and Novagen. With more than 34,000 employees in 55 countries, the Merck Group generated sales of EUR 7.5 billion in 2001. Founded in 1668 in Darmstadt, Germany, the company aims to be a world leader in its core businesses of pharmaceuticals and chemicals. The Merck Group strongly believes the key to its long-term business success is innovative products created by entrepreneurial and talented employees. Merck groups its operating activities under Merck KGaA, in which the Merck family holds 74% and the remaining 26% is publicly traded. The former U.S. subsidiary, Merck & Co., has been a completely independent company since 1917.
For more information, contact:
EMD Biosciences, Inc., 441 Charmany Drive, Madison, WI 53719, USA; Telephone: (800) 526-7319 (U.S. & Canada only) or (608) 238-6110; Fax (608) 238-1388.
Website: www.emdbiosciences.com
Media Contact:
Mark Lepinske
EMD Biosciences, Inc.
(608) 442-4020
mark.lepinske@emdbiosciences.com
|
